Application segmentation dissects the Correlative Light and Electron Microscopy (CLEM) Solutions market by end‑use domains, revealing distinct demand drivers. Life sciences research—encompassing cellular biology, neurobiology, and pathology—accounts for the largest share, as researchers require simultaneous optical and ultrastructural data to elucidate complex biological mechanisms. Materials science leverages CLEM for nanomaterial characterization, polymer‑matrix interfaces, and failure analysis, contributing a moderate but growing portion of revenue due to increasing investment in advanced composites. Semiconductor inspection utilizes CLEM to correlate photolithographic patterns with sub‑nanometer defect structures, a niche segment that commands premium pricing despite limited volume. Clinical diagnostics represents an emerging slice, where integrated imaging supports rapid pathogen identification and tissue‑level biomarker validation, though adoption remains constrained by regulatory pathways. Collectively, these application categories define the overall market size, with each segment’s growth rate reflecting its specific R&D intensity, capital expenditure, and regulatory environment. This analytical breakdown underpins the broader Correlative Light and Electron Microscopy (CLEM) Solutions segmentation framework.